New York State Common Retirement Fund
ORMP icon

New York State Common Retirement Fund’s Oramed Pharmaceuticals ORMP Stock Holding History

New York State Common Retirement Fund’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-260
Closed -$1K – 3402
2022
Q2 		$1K Sell
260
-21,404
-99% -$114K ﹤0.01% 3387
2022
Q1 		$187K Sell
21,664
-881
-4% -$9.03K ﹤0.01% 2843
2021
Q4 		$322K Buy
22,545
+4,576
+25% +$95.7K ﹤0.01% 2673
2021
Q3 		$395K Sell
17,969
-4,931
-22% -$84K ﹤0.01% 2597
2021
Q2 		$306K Buy
+22,900
New +$262K ﹤0.01% 2838

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund's ORMP Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Oramed Pharmaceuticals (ORMP) in Q3 2022, closing a stake of 260 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in ORMP in Q2 2021 and held it in 5 quarters. The position peaked at $395K in Q3 2021. 71 funds tracked by Wall St. Rank hold ORMP as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Oramed Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 260 Oramed Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • New York State Common Retirement Fund's Oramed Pharmaceuticals position peaked at $395K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.